Federal Policy
Latham & Watkins September 2026 Drug Pricing Digest Compiles Recent Policy Developments
Latham & Watkins published its September 2026 Drug Pricing Digest, tracking recent developments in the Medicaid Drug Rebate Program, 340B Program, Medicare, and state drug pricing laws. The digest compiles regulatory updates, guidance, and legal developments affecting pharmaceutical manufacturers and payers. This monthly reference document provides a consolidated view of drug pricing policy changes across federal and state programs. Medicaid agencies and managed care plans use these updates to track rebate program changes, 340B compliance requirements, and state legislative activity affecting drug costs.
Why it mattersConsolidated tracking of Medicaid rebate program changes, 340B policy, and state drug pricing laws helps state agencies and health plans monitor compliance obligations and cost management strategies.